NEPH Stock Analysis: Buy, Sell, or Hold?
NEPH - Nephros Inc.
$3.40
0.03 (0.89%)
▲
5d:
+3.98%
30d:
-10.53%
90d:
+14.86%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When NEPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NEPH shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: NEPH shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: NEPH is currently trading at $3.40, which is considered fair relative to its 30-day fair value range of $3.24 to $3.62. From a valuation perspective, the stock is trading at a premium (Forward PE: 34.0) compared to its historical average (28.9). At these levels, the market is pricing in 5.5% annual earnings growth.
Technical Outlook: Technically, NEPH is in a downtrend. Immediate support is located at $3.25, while resistance sits at $3.82.
Market Sentiment: NEPH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+105.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NEPH is in a downtrend. Immediate support is located at $3.25, while resistance sits at $3.82.
Market Sentiment: NEPH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+105.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.24 -
$3.62
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.7%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 105.9% below Wall St target ($7.00)
- BULLISH: Expecting earnings turnaround to 5.5% growth with 6.9% revenue growth
Trading Range Analysis
30-Day Trading Range
$3.24 -
$3.62
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.25
Resistance Level
$3.82
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
34.00
Wall Street Target
$7.00
(+105.9%)
Revenue Growth (YoY)
6.9%
Earnings Growth (YoY)
-80.0%
Profit Margin
4.1%
Valuation Premium vs History
+5.5% premium
PE vs Historical
34.0 vs 28.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.5%
(market-implied from PE analysis)
1-Year Target
$3.59
(+6%)
2-Year Target
$3.78
(+11%)
3-Year Target
$3.99
(+17%)
3-Yr Target (if PE normalizes)
(PE: 34→29)
PE COMPRESSION
$3.39
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 34.0, Growth: 122.2%)
$11.48
(+238%)
Base:
(SPY PE: 21.8, Growth: 122.2%)
$7.35
(+116%)
Bear:
(PE: 18.5, Growth: 122.2%)
$6.25
(+84%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (48x PE), but valuation improves significantly next year (34x PE) as earnings recover.
Trailing PE: 48.14 | Current EPS (TTM): $0.07
Bull Case
$5.30
(+56%)
Analyst growth 42.9%, PE expands to 53.0
Base Case
$4.81
(+42%)
Market implied 42.9%, PE stable at 48.1
Bear Case
$2.29
(-33%)
Severe decline -20.0%, PE contracts to 40.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 02, 2026 10:46 PM ET
Data refreshes hourly during market hours. Next update: 11:46 PM
Data refreshes hourly during market hours. Next update: 11:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 65 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 60 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$261 | 67 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
